Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cancer metastasis]

M F Poupon1

  • 1URA 620 CNRS, service de biologie, institut Curie, Paris, France.

Bulletin Du Cancer
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Metastasis involves tumor cells acquiring specific functions to spread to distant organs. Successful metastatic foci form through complex interactions between tumor and host cells, creating a unique ecosystem.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[A new model of human prostate cancer, the PAC120 xenograft].

Pathologie-biologie·2003
Same author

[Molecular and cell aspects of the cancer metastasis].

Acta cientifica venezolana·2002
Same author

Bone sialoprotein, bone morphogenetic protein 6 and thymidine phosphorylase expression in localized human prostatic adenocarcinoma as predictors of clinical outcome: a clinicopathological and immunohistochemical study of 43 cases.

The Journal of urology·2001
Same author

Single alteration of p53 or E-cadherin genes can alter the surgical resection benefit in an experimental model of colon cancer.

Diseases of the colon and rectum·2001
Same author

Clinical and experimental progression of a new model of human prostate cancer and therapeutic approach.

The American journal of pathology·2001
Same author

Distinct experimental efficacy of anti-Fas/APO-1/CD95 receptor antibody in human tumors.

Experimental cell research·2001
Same journal

[ONCONNECTE À L'EMPLOI, feedback after three years of a program to prepare for returning to work after cancer in Franche-Comté].

Bulletin du cancer·2026
Same journal

[Off-label use of venetoclax in myeloma].

Bulletin du cancer·2026
Same journal

[Cemiplimab - Adjuvant treatment for the cutaneous squamous cell carcinomas with high risk of relapse, operated and treated by radiotherapy].

Bulletin du cancer·2026
Same journal

Real-world outcomes and management of endometrial cancer in France from 2016 to 2021 (MOONBEAM study).

Bulletin du cancer·2026
Same journal

[Cardiotoxicity in children and adolescents with acute leukemia: Recommendations from the Leukemia Committee of the French Society of Childhood Cancer (SFCE)].

Bulletin du cancer·2026
Same journal

[Reirradiation: A new therapeutic paradigm in oncology].

Bulletin du cancer·2026
See all related articles

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Context:

  • Metastasis is a complex, multi-step process crucial to cancer progression and patient mortality.
  • Understanding the genetic and cellular events driving metastatic function is key to developing effective therapies.

Purpose:

  • To elucidate the multifaceted nature of metastatic function acquisition in tumor cells.
  • To describe the essential components and interactions required for the formation of metastatic foci.

Summary:

  • Metastasis originates from primary tumor cells acquiring specific genetic traits, leading to metastatic function.
  • This function includes loss of cell adhesion, enhanced angiogenesis, increased motility, invasiveness, and immune evasion.
  • Metastatic foci develop from a symbiotic ecosystem involving both tumor and host cells.

Related Experiment Videos

Impact:

  • Provides a comprehensive overview of the cellular and molecular mechanisms underlying cancer metastasis.
  • Highlights the critical role of the tumor microenvironment and host-tumor interactions in metastatic progression.
  • Informs future research directions for targeting metastatic disease.